This page lists feature articles on COVID-19 relevant to people working at St Vincent's Health Australia.
All articles listed are open access unless stated otherwise.
Clinical Practice
Prospective study of policies and use of therapies for COVID-19 amongst Australian health services during 2020. AUS
Internal Medicine Journal:2021: September 6 Full text
Changing patterns in Australian and New Zealand: vascular surgery during COVID-19. AUS
ANZ Journal of Surgery: 2021: September 4 Full text
Emergency department encounters among youth with suicidal thoughts or behaviors during the COVID-19 pandemic.
JAMA Psychiatry:2021: September 1 Full text
Epidemiology
A systematic review and meta-analysis of the characteristics and outcomes of readmitted COVID-19 survivors. AUS
Internal Medicine Journal:2021: September 6 Full text
Risk factors and disease profile of post-vaccination SARS-CoV-2 infection in UK users of the COVID Symptom Study app: a prospective, community-based, nested, case-control study.
Lancet Infectious Diseases:2021: September 1 Full text
Vaccine Efficacy
Comparison of SARS-CoV-2 antibody response by age among recipients of the BNT162b2 vs the mRNA-1273 Vaccine.
JAMA Network Open:2021: September 2 Full text
Evaluation of the SARS-CoV-2 antibody response to the BNT162b2 vaccine in patients undergoing hemodialysis.
JAMA Network Open:2021: September 2 Full text
Effectiveness of the mRNA BNT162b2 vaccine six months after vaccination: findings from a large Israeli HMO.
MedRxiv:2021: September 7 Full text
Effectiveness of Covid-19 vaccines in ambulatory and inpatient care settings.
New England Journal of Medicine:2021: September 8 Full text
Durability analysis of the highly effective BNT162b2 vaccine against COVID-19.
MedRxiv:2021: September 7 Full text
Vaccine Adverse Effects
Surveillance for adverse events after COVID-19 mRNA vaccination.
JAMA:2021: September 3 Full text
Immunology
Impact of temperature on the affinity of SARS-CoV-2 Spike glycoprotein for host ACE2.
Journal of Biological Chemistry:2021: August 31 Full text
Increased risk of severe clinical course of COVID-19 in carriers of HLA-C*04:01.
EClinical Medicine:2021: September 2 Full text
Ineffective neutralization of the SARS-CoV-2 Mu variant by convalescent and vaccine sera.
BioRxiv:2021: September 7 Full text
